Obstetric complications and neurological abnormalities in neuroleptic-naive psychotic patients

European Archives of Psychiatry and Clinical Neuroscience

Volumn 256, Issue 7, 2006, Pages 407-413

  Peralta, Victor ^a   Cuesta, Manuel J ^a   Serrano, Jose F ^a  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

Author keywords

Antipsychotic drugs; Basal ganglia; Drug naive state; Extrapyramidal symptoms; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BIPERIDEN; CHLORPROMAZINE; HALOPERIDOL; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; AKATHISIA; ANAMNESIS; ARTICLE; CATATONIA; CLINICAL ARTICLE; DISEASE PREDISPOSITION; DYSKINESIA; FEMALE; HOSPITAL PATIENT; HUMAN; MALE; MCNEIL SJOSTROM SCALE; MENTAL PATIENT; MONOTHERAPY; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEWBORN DISEASE; PARKINSONISM; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE;

ADULT; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 33750085601     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-006-0653-7     Document Type: Article

References (44)

1. Breslau N, Chilcoat HD, Johnson EO, Andreski P, Lucia VC (2000) Neurologic soft signs and low birthweight: their association and neuropsychiatric implications. Biol Psychiatry 47:71-79
2. Hediger ML, Overpeck MD, Ruan WJ, Troendle JF (2002) Birthweight and gestational age effects on motor and social development. Pediatr Perinatol Epidemiol 16:33-46
3. Lewis SW, Murray RM (1987) Obstetric complications, neurodevelopmental deviance and risk of schizophrenia. J Psychiatric Res 21:413-421
4. McNeil TF (1995) Perinatal risk factors and schizophrenia: selective review and methodological concerns. Epidemiol Rev 17:107-112
5. McNeil TF, Cantor-Graae E, Weinberger DR (2000) Relationship of obstetric complications and differences of brain structures in monozygotic twin pairs discordant for schizophrenia. Am J Psychiatry 157:203-202
6. Falkai P, Schneider-Axmann T, Honer WG, Vogeley K, Schönell H, Pfeiffer P, Scherk H, Block W, Träber F, Schild HH, Maier W, Tepest R (2003) Influence of genetic loading, obstetric complications and premorbid adjustment on brain morphology in schizophrenia: A MRI study. Eur Arch Psychiatry Clin Neurosci 253:92-99
7. McCreadie RG, Hall DJ, Berry IJ, Robertson LJ, Ewing JI (1992) The Nithsdale Schizophrenia Surveys X: Obstetric complications, family history and abnormal movements. Br J Psychiatry 162:799-805
8. Cantor-Graae E, McNeil T, Rickler KC, Sjöström K, Rawlings R, Higgins ES, Hyde TM (1994) Are neurological abnormalities in well discordant monozygotic co-twins of schizophrenic subjects the result of perinatal trauma? Am J Psychiatry 151:1194-1199
9. Cantor-Graae E, Ismail B, McNeil TF (2000) Are neurological abnormalities in schizophrenic patients and their siblings the result of perinatal trauma? Acta Psychiat Scand 101:142-147
10. Lane A, Colgan K, Moynihan F, Burke T, Waddington JL, Larkin C, O'Callaghan E (1996) Schizophrenia and neurological soft signs: gender differences in clinical correlates and antecedent factors. Psychiatry Res 64:105-114
11. Ismail B, Cantor-Graae E, McNeil TF (2001) Neurodevelopmental origins of tardivelike dyskinesia in schizophrenic patients and their siblings. Schizophr Bull 27:29-642
12. Waddington JL, Youssef HA (1987) Is schizophrenia a neurodevelopmental disorder? Br Med J 295:997-998
13. Rifkin A, Quitkin F, Klein DF (1975) Akinesia: a poorly recognized drug-induced extrapyramidal disorder. Arch Gen Psychiatry 32:672-675
14. Gelenberg AJ, Mandel MR (1977) Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry 34:947-950
15. Delgalarrondo P, Gattaz WF (1994) Basal ganglia abnormalities in tardive dyskinesia. Possible relationship with duration of neuroleptic treatment. Eur Arch Psychiatry Clin Neurosci 244:272-277
16. Fernandez HH, Krupp B, Friedman JH (2001) The course of tardive dyskinesia and parkinsonism in psychiatric inpatients: 14 year follow-up. Neurology 56:805-807
17. Martényi F, Metcalfe S, Schausberger B, Dossenbach MRK (2001) An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms. J Clin Psychiatry 62:25-27
18. Peralta V, Cuesta MJ (1999) Negative, parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigms revisited. Schizophr Res 40:245-253
19. McNeil TF, Cantor-Graae E, Sjöström K (1994) Obstetric complications as antecedents of schizophrenia: empirical effects of using different obstetric complication scales. J Psychiat Res 28:519-530
20. McNeil TF, Cantor-Graae E, Nordström LG, Roselund T (1997) Does choice of scale for scoring obstetric complications influence their relationship to other etiological risks factors in schizophrenia? J Nerv Mental Dis 185:27-31
21. Andreasen NC, Flaum M, Arndt S (1992) The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 49:615-623
22. Andreasen NC, Endicott J, Spitzer RL, Winokur G (1977) The family history method using diagnostic criteria: reliability and validity. Arch Gen Psychiatry 34:1229-1235
23. McNeil TF, Sjöström K (1995) McNeil-Sjöstrom Scale for Obstetric Complications. Lund University Department of Psychiatry, Malmö University Hospital, Malmö, Sweden
24. Simpson GM, Angus JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiat Scand 212:11-19
25. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Washington DC, US Department of Health, Education, and Welfare, pp 534-537
26. Barnes TRE (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:672-676
27. McKenna PJ, Lund CE, Mortimer AM, Biggins CA (1991) Motor, volitional and behavioural disorders in schizophrenia 2: The 'conflict of paradigms' hypothesis. Br J Psychiatry 158:328-336
28. Buchanan RW, Heinrichs DW (1989) The Neurological Evaluation Scale: a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res 27:335-350
29. Arndt S, Turvey C, Andreasen NC (1999) Correlating and predicting psychiatric symptom ratings: Spearman's r versus Kendall's tau correlation. J Psychiatr Res 33:97-104
30. Peralta V, Cuesta MJ (2001) Motor features in psychotic disorders. I. Factor structure and clinical correlates. Schizophr Res 47:107-116
31. Rosso IM, Bearden CE, Hollister JM, Gasperoni TL, Sanchez L, Hadley T, Cannon TD (2000) Childhood neuromotor dysfunction in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull 26:367-378
32. Stewart AL, Rifkin L, Amess PN, Kirkbride V, Towsed JP, Miller DH, Lewis SW, Kingsley DPE, Moseley IF, Foster O, Murray RM (1999) Brain structure and neurocognitive and behavioural function in adolescents who were born very preterm. Lancet 353:1653-1657
33. Henn FA, Braus DF (1999) Structural neuroimaging in schizophrenia. An integrative view from the neuromorphology. Eur Arch Psychiatry Clin Neurosci 249(Suppl. 4):48-56
34. Flashman LA, Flaum M, Gupta S, Andreasen NC (1996) Soft signs and neuropsychological performance in schizophrenia. Am J Psychiatry 153:526-532
35. Keshavan MS, Sanders RD, Sweeney JA, Diwadkar VA, Goldstein G, Pettegrew JW, Schooler NR (2003) Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. Am J Psychiatry 160:1298-1304
36. Dazzan P, Morgan KD, Orr KG, Hutchinson G, Chitnis X, Suckling J, Fearon P, Salvo J, McGuire PK, Mallet RM, Jones PB, Leff J, Murray RM (2004) The structural brain correlates of neurological soft signs in AESOP first-episode schizophrenia study. Brain 127:143-53
37. Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek PA, Trenary M, Tafalla R, Reinolds C, Bunney WE Jr (1992) Frontoestriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 49:935-942
38. Keshavan MS, Rosenberg D, Sweeney JA, Pettegrew JW (1998) Decreased caudate volume in neuroleptic-naive psychotic patients. Am J Psychiatry 155:774-778
39. Schmitt GJ, Frold T, Dresel S, la Fougere C, Bottlender R, Koutsouleris N, Hahn K, Möller HJ, Meisenzahl EM (2006) Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 256:115-121
40. Hansen TW (2001) Bilirubin brain toxicity. J Perinatology 21(suppl. 1):48-51
41. Cantor-Graae E, Cardenal S, Ismail B, McNeil TF (1998) Recall of obstetric events by mothers of schizophrenic patients. Psychol Med 28:1239-1243
42. Browne S, Clarke M, Gervin M, Lane A, Waddington JL, Larkin C, O'Callaghan E (2000) Determinants of neurological dysfunction in first episode schizophrenia. Psychol Med 30:1433-1441
43. Rothman KJ, Greenland S (1998) Modern Epidemiology. Lippincott Williams & Wilkins, Philadelphia, PA, pp 225-229
44. Bacchetti P (2002) Peer review of statistic in medical research: the other problem. Br Med J 324:1271-1273